Huateng Pharma Supplies Ensitrelvir Intermeidates Against CO

Ensitrelvir (code name S-217622, brand name Xocova), is a new inhibitor of the SARS-CoV-2 major protease (Mpro), also known as 3C-like protease, has been shown to reduce the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters. In cells, low nanomolar to sub-micromolar doses of Ensitrelvir suppress viral growth.

Related Keywords

China , Japan , Japanese , Huateng Pharma , , Epidemic , Infection , Manufacturing , Medical Specialties , Project Management , Promotion , Supply Chain Management , 3c Like Protease , Antiviral Drugs , Atypical Pneumonias , Coronavir , Coronaviridae , Covid 19 Drug Development , Sarbecovirus , Sars , Severe Acute Respiratory Syndrome Coronavirus 2 , Viruses ,